Details for New Drug Application (NDA): 012882
✉ Email this page to a colleague
NDA 012882 describes ISORDIL, which is a drug marketed by Wyeth Ayerst, Bausch, and Biovail, and is included in three NDAs. It is available from two suppliers. Additional details are available on the ISORDIL profile page.
The generic ingredient in ISORDIL is isosorbide dinitrate. There are thirty-seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the isosorbide dinitrate profile page.
The generic ingredient in ISORDIL is isosorbide dinitrate. There are thirty-seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the isosorbide dinitrate profile page.
Summary for 012882
| Tradename: | ISORDIL |
| Applicant: | Wyeth Ayerst |
| Ingredient: | isosorbide dinitrate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 012882
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 40MG | ||||
| Approval Date: | Jul 29, 1988 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 40MG | ||||
| Approval Date: | Jul 29, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
